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Abstract
Minimally invasive distal pancreatectomy with splenec-
tomy has been regarded as a safe and effective treat-
ment for benign and borderline malignant pancreatic 
lesions. However, its application for left-sided pancre-
atic cancer is still being debated. The clinical evidence 
for radical antegrade modular pancreatosplenectomy 
(RAMPS)-based minimally invasive approaches for left-
sided pancreatic cancer was reviewed. Potential indi-
cations and surgical concepts for minimally invasive 
RAMPS were suggested. Despite the limited clinical 
evidence for minimally invasive distal pancreatectomy 
in left-sided pancreatic cancer, the currently available 
clinical evidence supports the use of laparoscopic dis-
tal pancreatectomy under oncologic principles in well-
selected left sided pancreatic cancers. A pancreas-
confined tumor with an intact fascia layer between the 
pancreas and left adrenal gland/kidney positioned more 
than 1 or 2 cm away from the celiac axis is thought to 
constitute a good condition for the use of margin-neg-
ative minimally invasive RAMPS. The use of minimally 
invasive (laparoscopic or robotic) anterior RAMPS is 
feasible and safe for margin-negative resection in well-
selected left-sided pancreatic cancer. The oncologic 
feasibility of the procedure remains to be determined; 
however, the currently available interim results indicate 
that even oncologic outcomes will not be inferior to 
those of open radical distal pancreatosplenectomy. 
© 2014 Baishideng Publishing Group Co., Limited. All rights 
reserved.
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Core tip: Minimally invasive (laparoscopic or robotic) rad-
ical distal pancreatosplenectomy is technically feasible 
and safe for margin-negative resection in well-selected 
left sided pancreatic cancer. Generally acceptable po-
tential indications are proposed to include the following: 
(1) pancreas-confined tumors; (2) intact fascia layer 
between the distal pancreas and left adrenal gland/kid-
ney; and (3) tumor 1-2 cm from celiac axis. The long-
term oncologic feasibility remains to be discerned, but 
the currently available interim results are encouraging. 
Further clinical experience with this minimally invasive 
approach for left-sided pancreatic cancer should be ac-
cumulated by experienced surgeons. In the near future, 
surgical approaches should be specified according to the 
conditions of the individual pancreatic cancer case.
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INTRODUCTION
With recent advancements in laparoscopic experience, tech-
niques, and instruments, laparoscopic surgery has replaced 
conventional open surgery in most general surgical fields, 
even in cancer surgery. Despite the potential limitations of  
conventional laparoscopic surgery, many studies have prov-
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en the oncologic feasibility and rationale for laparoscopic 
surgery in various malignant diseases, such as cancers of  
the esophagus[1,2], stomach[3,4], liver[5], colon[6,7], etc. However, 
it remains controversial whether minimally invasive surgery 
should be applied to treat pancreatic cancer.
Pancreatic cancer is known to be one of  the most 
lethal gastrointestinal malignancies. As a monotherapy, 
margin-negative pancreatectomy can provide the essential 
clinical conditions for cure, but the resection rate is very 
low due to the advanced cancer stages that are usually 
present at the initial diagnosis. In addition, surgical tech-
niques for margin-negative radical pancreatectomy are very 
difficult and complex procedures, even in the conventional 
open approach. Therefore, many surgeons greatly fear that 
the risk of  incomplete surgery might arise when applying 
minimally invasive techniques to treat pancreatic cancers. 
Moreover, the lack of  more advanced laparoscopic tech-
niques and the limited amount of  clinical evidence are 
some of  the biggest obstacles to the use of  laparoscopic 
approaches in the treatment of  pancreatic cancer. 
Still, several currently available studies have suggested 
that patients with pancreatic cancer may have appropri-
ate backgrounds for the use of  a minimally invasive ap-
proach to treat well-selected left-sided pancreatic cancers. 
First, unlike laparoscopic pancreaticoduodenectomy, 
laparoscopic distal pancreatectomy is generally regarded 
as a safe and effective treatment modality in benign and 
borderline malignant diseases[8]. Second, even laparo-
scopic subtotal (or extended) distal pancreatectomy can 
be feasible and safe[9]. Third, many laparoscopic gastric 
surgeons have already proven the oncologic safety and 
feasibility of  laparoscopic perigastric lymph node dis-
section in the treatment of  gastric cancer[10]. Fourth, the 
concept of  radical antegrade modular pancreatosplenec-
tomy (RAMPS)[11] is thought to be a reasonable approach 
for margin-negative and systemic lymph node clearance 
in left-sided pancreatic cancer. Fifth, the early detection 
of  small and asymptomatic pancreatic cancer is expected 
to increase in the near future due to frequent routine 
medical check-ups. Finally, even though the data remain 
limited, a few encouraging studies have been published 
on the feasibility of  a minimally invasive approach to 
pancreatic cancer[12-14].
Various types of  minimally invasive pancreatectomy are 
currently feasible; however, in this review, we will address 
distal pancreatosplenectomy in the treatment of  pancreatic 
cancer because this surgical procedure is popular and gen-
erally regarded as safe. Therefore, it is thought that laparo-
scopic distal pancreatectomy with splenectomy could be 
the initial step for generalizing the concept of  a minimally 
invasive approach to well-selected pancreatic cancers.
CONCEPT OF RAMPS AS A MINIMALLY 
INVASIVE (LAPAROSCOPIC OR ROBOTIC) 
APPROACH
Strasberg et al[11,15] presented this modified distal pancreato-
splenectomy technique in pancreatic cancer. In this meth-
od, dissection proceeds from right to left after an early di-
vision of  the pancreatic neck on one of  the two posterior 
dissection planes to achieve negative posterior resection 
margins. The plane of  dissection runs posteriorly in the 
sagittal plane along the superior mesenteric artery and ce-
liac artery to the level of  the aorta and then laterally, either 
anterior or posterior to the adrenal gland, for tangential 
margin clearance. The accompanying N1 lymph node dis-
section is based on the established anatomy of  lymphatic 
drainage of  the pancreas. The posterior dissection plane 
can be actively placed for tangential margin clearance. Ac-
cording to the posterior dissection plane of  the pancreas, 
three types of  RAMPS can be generally classified (Figure 
1). Compared to the usual conventional technique for 
distal pancreatosplenectomy (dissection from left to right 
first and vascular control later[16]), RAMPS is thought to be 
more in line with general oncologic concepts, such as early 
vascular control and no-touch isolation with en bloc surgi-
cal resection. Therefore, when applying minimally invasive 
approaches to left-sided pancreatic cancer, the principles 
behind RAMPS should be incorporated, although the 
generally acceptable extent to which minimally invasive 
RMAPS can be applied must be determined first. 
DETERMINING THE EXTENT OF 
MINIMALLY INVASIVE RAMPS AND 
POTENTIAL INDICATIONS
According to our surgical experiences with left-side pan-
creatic cancer, bloodless and margin-negative resection is 
an important factor in treating left-sided pancreatic can-
cer[14]; other reports have also supported this finding[17,18]. 
However, the use of  combined adjacent organ resection 
has been associated with large amounts of  intraoperative 
bleeding, transfusion, morbidity, and increased risks of  a 
positive resection margin[19,20]. 
When correlating between the RAMPS surgical mode 
and the potential tumor behavior, several relationships can 
be identified (Figure 2, solid line). For example, in the case 
where posterior RAMPS 2 is selected for margin-negative 
resection, as opposed to anterior RAMPS, there is a high 
probability of  a large tumor size, combined resection of  
adjacent organs, large amounts of  intraoperative bleed-
ing, and perioperative transfusions, as well as technically 
demanding, more aggressive tumor behaviors, such as 
actual margin positivity, peritoneal seeding, or hidden dis-
tant metastasis. In contrast, when considering the current 
technical feasibility of  minimally invasive distal pancre-
atosplenectomy for bloodless and margin-negative resec-
tions, minimally invasive anterior RAMPS is well accepted; 
however, it would be very technically difficult to obtain 
margin-negative and bloodless resections in the case of  
minimally invasive posterior RAMPS 1 or RAMPS 2 (Fig-
ure 2, dotted line). Certainly, minimally invasive posterior 
RAMPS 1 and RAMPS 2 are also feasible [Figure 2, areas 
(B) and (C)], but it is thought that only a few expert lapa-
roscopic surgeons can be fully responsible for those de-
manding surgical procedures[21]. Therefore, it is generally 
recommended that open aggressive pancreatectomy only 
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be performed for patients requiring posterior RAMPS 1 
and 2. Consequently, when generalizing the concept of  
minimally invasive approaches to left-sided pancreatic 
cancer, it would be wise to limit the procedure to anterior 
RMAPS alone [Figure 2, area (A)][22]. This surgical ex-
tent will cover following potential tumor conditions: (1) 
pancreas-confined tumors; (2) intact fascia layer between 
the distal pancreas and left adrenal gland/kidney; and (3) 
tumor 1-2 cm from celiac axis (Figures 3 and 4).
CURRENT CLINICAL PRACTICE OF THE 
MINIMALLY INVASIVE APPROACH TO 
LEFT-SIDED PANCREATIC CANCER
Primitive evidence
Until now, many studies have proven the clinical benefit 
of  laparoscopic distal pancreatectomy, with or without 
splenectomy, in benign and borderline malignant pan-
creatic disease. However, only a few previous studies 
have reported the laparoscopic approach for left-sided 
pancreatic cancer with available long-term survival out-
comes[12,23-27]. Since Gagner et al[28] first reported laparo-
scopic distal pancreatectomy, with the advance of  laparo-
scopic techniques and experiences, several other studies 
have been published, showing the technical feasibility, 
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Figure 1  Mode of radical antegrade modular pancreatosplenectomy. 
A: Anterior radical antegrade modular pancreatosplenectomy (RAMPS); B: 
Posterior RAMPS 1; C: Posterior RAMPS 2. Dissection plane (yellow line) 
should be changed for clear tangential margin according to tumor condition (red 
circle).
Figure 2  Determining the extent of minimally invasive radical antegrade 
modular pancreatosplenectomy. The dotted line shows the technical feasibil-
ity of bloodless and margin-negative radical antegrade modular pancreatosple-
nectomy (RAMPS) by a minimally invasive approach, and the solid line rep-
resents the biological aggressiveness of tumors, according to the appropriate 
mode of RAMPS for margin-negative resection. Tentatively, minimally invasive 
anterior RAMPS is thought to represent a generally acceptable surgical extent 
for bloodless and margin-negative resections. Oncologically safe posterior 
RAMPS 1 and 2 might be difficult to perform using a minimally invasive ap-
proach. Note the marginal zone of (B). Only a few expert laparoscopic surgeons 
can be fully responsible for this region. Future directions include widening the 
area of (B) by means of technical evolution (shifting of the dotted line to the left) 
and improving early tumor detection (attenuating the slope of solid line). MIS: 
Minimally invasive surgery.
MIS
(A) (B) (C)
Open aggressive 
surgery
Anterior RAMPS Posterior RAMPS 1 Posterior RAMPS 2
Surgical mode of RAMPS
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Figure 3  Potential indication for minimally invasive anterior radical ante-
grade modular pancreatosplenectomy. A 76-year-old female. A relatively pan-
creas-confined low density mass lesion is noted (arrow). The dotted white line 
indicates the dissection plane for minimally invasive anterior radical antegrade 
modular pancreatosplenectomy (RAMPS). The intact fascia layer between the 
pancreas and left adrenal gland/kidney can facilitate posterior margin clearance 
when removing the surgical specimen. The tumor is separated from the origin of 
the splenic artery, necessary for safe vascular control by introducing a minimally 
invasive technique. The patient underwent laparoscopic anterior RAMPS and 
has been followed for more than 1 year without evidence of tumor recurrence.
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3.0-13.0), P = 0.29] were shown to be comparable with 
those in a conventional open approach. 
A recent multicenter analysis reported by Kooby et al[13] 
has provided the most encouraging and impressive evidence, 
considering the lack of  long-term oncologic evidence of  
laparoscopic approaches to left-sided pancreatic cancer. 
This study showed that laparoscopic distal pancreatectomy 
is able to provide similar short- and long-term oncologic 
outcomes to those obtained with open distal pancreatec-
tomy and suggested that laparoscopic distal pancreatec-
tomy is an acceptable approach for the resection of  the 
left-sided pancreatic cancer in selected patients. In the 
matched analysis of  the overall survival for the patients 
undergoing an open (n = 70) versus a laparoscopic distal 
pancreatectomy (n = 23) for pancreatic cancer, the median 
survival was comparable among the two the groups (me-
dian 16 mo, P = 0.71). 
In addition, Kim et al[35] also published the long-
term outcomes of  patients who were postoperatively 
diagnosed with malignancies after laparoscopic distal 
pancreatectomy. Of  the 88 patients who underwent a 
laparoscopic distal pancreatectomy, 11 (12.5%) were 
subsequently diagnosed with malignancies in their post-
operative pathologic reports. Pancreatic ductal adeno-
carcinoma was the most common (5 out of  11 patients), 
followed by invasive intraductal papillary mucinous neo-
plasm (n = 3), neuroendocrine carcinoma (n = 1), and 
so forth. During the follow-up period (range, 3-60 mo), 
they reported only 1 patient who died of  cancer; all oth-
ers were still alive. Thus, the authors carefully concluded 
that the postoperative outcomes among patients who 
were diagnosed postoperatively with malignant pancre-
atic disease are acceptable. 
Although these retrospective studies were not able 
to suggest either standardized surgical procedures or 
proper indications, they did suggest potential oncologic 
outcomes and verify the technical feasibility of  the lapa-
roscopic approach to left-sided pancreatic cancer. 
Recent advance evidence
More encouraging clinical data with intent-to-treat for 
safety, and clinical benefit of  laparoscopic distal pan-
createctomy over open distal pancreatectomy. However, 
most reported cases of  pancreatic cancer (ductal adeno-
carcinoma) treated by laparoscopic distal pancreatectomy 
were incidentally included in those series. As a result, we 
cannot fully assess the surgical quality based on relevant 
oncologic concepts. In addition, the lack of  informa-
tion on tumor characteristics, such as pT stage, pN stage, 
number of  retrieved lymph nodes, margin status, and 
survival outcomes, creates difficulties in determining the 
oncologic feasibility of  the laparoscopic approach to the 
left-sided pancreatic cancer[24-27,29,30]. For example, in one 
collective review performed in 2009[31], a final diagnosis 
of  pancreatic ductal adenocarcinoma was found in 51 pa-
tients (9.8%, 51 out of  588 patients). However, the mar-
gin status was available in only 20 patients (39%). In addi-
tion, the number of  retrieved lymph nodes in patients with 
pancreatic cancer was reported in only three articles[26,32,33] 
(12.5%, 3 of  24 articles identified). Not surprisingly, there 
is still a lack of  long-term survival outcomes. Despite the 
efforts of  several surgeons to perform laparoscopic distal 
pancreatectomy for pancreatic cancer, it was found that 
there is a substantial lack of  evidence on the oncologic 
outcomes and surgical quality. Consequently, for the last 
several decades, we were uncertain whether the minimally 
invasive approach to left-sided pancreatic cancer was ap-
propriate. 
Intermediate evidence
Recently, several studies have been published that focused 
on the question of  whether laparoscopic distal pancre-
atectomy is oncologically feasible. 
DiNorcia et al[34] reported their experiences with lapa-
roscopic distal pancreatectomy between 1991 and 2009. 
Seventy-one patients underwent laparoscopic distal pan-
createctomy, and only 9 patients (12.7%) were reported 
to have malignant pathologies, including 3 cases of  pan-
creatic ductal adenocarcinoma. Long-term survival out-
comes were not analyzed; however, the margin-negative 
resection rate (2.8% vs 13%, P < 0.01) and mean number 
of  retrieved lymph nodes [6 (range: 2.5-12.0) vs 8 ( range: 
BA
Figure 4  Adequate distance between celiac axis and tumor. Robotic anterior radical antegrade modular pancreatosplenectomy. The origin of the splenic artery is 
isolated (A) and ligated (B) by the robotic surgical system. For technically and oncologically safe minimally invasive vascular control, some cancer-free space is ex-
tremely necessary. 
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during laparoscopic distal pancreatectomy, the margin-
positive resection rate was reported to be 4%, and the 
capacity for lymph node retrieval was up to 17 (range 
10-19); these results are comparable with those of  ro-
botic distal pancreatectomy [R1 resection rate, 0% and 
nodal harvested, median 19 (range 17-27)], suggesting 
an acceptable quality of  surgery in treating pancreatic 
cancer. They also analyzed retrospective 62 consecutive 
patients undergoing open distal pancreatectomy (ODP = 
34) and minimally invasive distal pancreatectomy (MIDP 
= 28 with 5 conversions) for pancreatic ductal adenocar-
cinoma[40]. It was shown that overall survival after ODP 
or intended MIDP was similar after adjusting for comor-
bidity and year of  surgery [relative hazard, 1.11 (95%CI: 
0.47-2.62)]. These two studies still lack long-term onco-
logic outcomes (median follow up of  21 mo), however, 
no evidence was detected that MIDP was inferior to 
ODP in treating pancreatic cancer.
On the other hand, Marangos et al[41] published an 
interesting paper about their surgical experiences with 
laparoscopic distal pancreatosplenectomy for pancreatic 
exocrine carcinoma. Since 1997, they reported removing 
all lesions in the body and tail of  the pancreas laparo-
scopically, and 29 patients with pancreatic cancer (11.6%, 
29 out of  250 patients) underwent laparoscopic distal 
pancreatosplenectomy. Their approach was not based 
on RAMPS but rather on the conventional left-to-right 
technique. In addition, they did not perform formal 
lymph node dissection; instead, they only removed the 
enlarged or suspicious regional lymph nodes. The dissec-
tion plane and resection margins were carefully guided 
by laparoscopic intraoperative ultrasound. They reported 
an overall 93% R0 resection rate with a median survival 
of  23 mo (in particular, 19 mo for 21 pancreatic ductal 
adenocarcinomas), which is also comparable to the best 
open series[15,42]. It was noted that the median number 
of  retrieved lymph nodes was smaller (5 nodes), but this 
did not translate into poor oncologic outcomes, again 
reminding us of  the outcomes of  previous prospec-
tive randomized controlled studies on standard and 
extended pancreaticoduodenectomy in the treatment of  
pancreatic head cancer[43-45]. In addition, in comparison 
with the oncologic outcomes from open radical surgery, 
perioperative and oncologic outcomes appear to be 
comparable between the minimally invasive radical distal 
pancreatectomy and the open approach (Table 1). One 
of  the most significant weak points of  the minimally 
invasive approach to pancreatic cancer is that the onco-
logic outcomes are still based on a short-term follow-up 
period, compared to that of  open radical pancreatec-
tomy[14,15,46-48]. However, recently, the single-center-based 
Pittsburgh group[40] reported a comparative analysis, in-
cluding long-term survival, of  34 patients with open radi-
cal pancreatectomy and 34 with minimally invasive distal 
pancreatectomy in pancreatic ductal adenocarcinoma to 
determine the oncological safety and efficacy of  mini-
mally invasive surgery. They demonstrated no significant 
difference between two groups in tumor size (3.0 cm vs 3.0 
cm), radiologic stage (ⅠA/ⅠB/ⅡA/ⅡB, 3/12/10/6 
vs 3/11/5/4), margin-negative resection (88% vs 86%), 
power of  lymph node retrieval (12 vs 11), or lymph node 
metastasis (38% vs 57%) and similar postoperative com-
plications, leading to equivalent survival in propensity 
score-adjusted overall survival analysis [relative hazard, 
1.11 (95%CI: 0.47-2.62), P = 0.80]. Along with the multi-
center case-matched analysis by Kooby et al[13], this study 
provides powerful evidence to support the technical 
feasibility of  minimally invasive radical oncologic sur-
gery. The study further shows that the quality of  surgical 
specimens is quite acceptable and provides encouraging 
oncologic survival outcomes. 
CHALLENGING ISSUES 
Combined and vascular resection
Distal pancreatectomy with en bloc celiac axis resection 
(DPCAR) has been introduced for locally advanced left-
sided pancreatic cancer involving the common hepatic 
artery and/or celiac axis, with perineural invasion in the 
nerve plexus surrounding these arteries[49,50]. In particular, 
Okada et al[50] recently concluded that DP-CAR is feasible 
and should be reserved for patients without tumors infil-
trating either the portal venous or arterial system. Consid-
ering these circumstances, DP-CAR is suggested to be a 
safe procedure, similar to standard distal pancreatectomy 
in well-selected patients. Recent technological innovations 
and extensive surgical experiences are expanding the clini-
cal applications for laparoscopic distal pancreatectomy. 
As a result, the technical feasibility of  minimally invasive 
distal pancreatectomy with combined celiac trunk or 
portal vein resection has also been reported. Cho et al[21] 
reported the technical feasibility of  pure laparoscopic 
DP-CAR, finding it safe and feasible to achieve R0 resec-
tions in selected patients with locally advanced pancreatic 
cancer. Giulianotti et al[51] and Boggi et al[52] also reported 
robotic pancreatectomy with vascular resection for locally 
advanced pancreatic tumors. In addition, Kendrick et al[53] 
reported 11 patients who underwent total laparoscopic 
pancreaticoduodenectomy with major venous vascular re-
section, including laparoscopic end-to-end vascular recon-
struction, patch, and renal vein graft. However, patients 
with left-sided pancreatic cancer invading isolated superior 
mesenteric vein-splenic vein-portal vein confluence are 
rare, as most cases of  pancreatic cancer are usually as-
sociated with celiac axis and superior mesenteric artery 
invasion[54], which will be determined as locally invasive 
pancreatic cancer (unresectable). In general, pancreatic 
surgeons must consider possible combined vascular re-
section in their surgical approaches to pancreatic cancer 
and should be prepared to meet this surgical demand. 
However, how many surgeons can be responsible for this 
advanced laparoscopic technique? How should the educa-
tional system be modified to reproduce this surgical skill? 
Is only RAMPS the ideal approach?
The surgical approach of  RAMPS has demonstrated 
favorable oncologic outcomes in treating left-sided pan-
creatic cancer[11,15,22,55]. The basic concept of  RAMPS is, 
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of  course, oncologically sound and reasonable; however, 
it is notable that no randomized controlled studies have 
tested the oncologic superiority between RAMPS and 
conventional radical distal pancreatectomy. There are 
several comparable reports showing similar survival out-
comes to RAMPS[14,41,56]. An RCT should be performed 
to test whether the RAMPS procedure is superior to 
standard distal pancreatectomy. However, it is very dif-
ficult to organize a successful trial. Mitchem et al[22] have 
already commented on this issue, as follows: “However, 
the disparity between the number of  cases available for 
study and the number required for a randomized trial 
makes this goal unattainable”.
FUTURE PERSPECTIVES ON MINIMALLY 
INVASIVE LEFT-SIDED RADICAL 
PANCREATECTOMY
As shown in other gastrointestinal cancer surgeries, there 
has been an increasing clinical effort to apply the laparo-
scopic approach to left-sided pancreatic cancer. However, 
procedural standardization and surgical indications have 
not yet been established. Currently, RAMPS seems to be 
a reasonable approach, with encouraging oncologic out-
comes in the treatment of  left-sided pancreatic cancer[22]. 
Nevertheless, it might be difficult to expand the use of  
minimally invasive RAMPS to all left-sided pancreatic 
cancers because these cancers are usually found in ad-
vanced cancer stages. However, the clinical conditions re-
quired to widen the area (B) in Figure 2, such as technical 
evolution (right sided-shift of  dotted line in Figure 2) and 
the early detection of  the cancer (attenuating slope of  
the solid line), would facilitate the clinical application of  
minimally invasive RAMPS in well-selected cases of  left-
sided pancreatic cancer. 
Recently, the use of  radical pancreatectomy followed 
by neoadjuvant chemoradiation therapy has been suc-
cessfully applied for the treatment of  advanced pancre-
atic cancers[57-59]. In considering the future circumstances 
of  potent chemoradiation therapy for the treatment of  
pancreatic cancers, minimally invasive RAMPS following 
neoadjuvant chemoradiation therapy would be another 
potential option for well-selected patients. In particular, 
considering the technical advances of  combined vascular 
resection in treating pancreatic cancer, the indications for 
minimally invasive radical distal pancreatectomy should 
be expanded in the near future. In addition, many aca-
demic institutions seem to be carefully accumulating clini-
cal experience with the minimally invasive resection of  
left-sided pancreatic cancer. Perhaps in the near future, 
more relevant clinical evidence with adequate long-term 
follow-up and qualified oncologic outcomes will become 
available, leading to the oncologic feasibility of  minimally 
invasive left-sided pancreatectomy in pancreatic cancers. 
Generally, these conclusions will be influenced by selec-
tion bias from the retrospective nature of  studies. How-
ever, these identified instances of  selection bias, in turn, 
will become potential selection criteria for minimally in-
vasive radical pancreatectomy in distal pancreatic cancers, 
especially given the difficulty of  establishing an RCT in 
the present circumstances.
CONCLUSION
More than 20 years have passed since the first laparo-
scopic cholecystectomy was performed in the late 1980s. 
Tremendous improvements in the surgical techniques, 
experiences, and new effective instruments have success-
fully expanded the indications for laparoscopic surgery. 
Minimally invasive (laparoscopic and robotic) radical pan-
createctomy in well-selected left-sided pancreatic cancers 
is feasible under general oncologic concepts; however, 
solid clinical evidence is still lacking. Further clinical 
experience with a minimally invasive approach to left-
side pancreatic cancer must be carefully accumulated by 
experienced surgeons. The oncological feasibility should 
be addressed in greater detail based on long-term survival 
outcomes. However, we should not overlook that the cur-
rently available interim results demonstrating minimally 
invasive left-sided radical pancreatectomy are not inferior 
to those of  conventional open radical pancreatectomy.
REFERENCES
1 Nguyen NT, Hinojosa MW, Smith BR, Chang KJ, Gray J, 
Hoyt D. Minimally invasive esophagectomy: lessons learned 
from 104 operations. Ann Surg 2008; 248: 1081-1091 [PMID: 
19092354 DOI: 10.1097/SLA.0b013e31818b72b5]
2 Smithers BM, Gotley DC, Martin I, Thomas JM. Compari-
son of the outcomes between open and minimally invasive 
esophagectomy. Ann Surg 2007; 245: 232-240 [PMID: 17245176 
DOI: 10.1097/01.sla.0000225093.58071.c6]
3 Huscher CG, Mingoli A, Sgarzini G, Sansonetti A, Di Paola 
M, Recher A, Ponzano C. Laparoscopic versus open subtotal 
gastrectomy for distal gastric cancer: five-year results of a 
randomized prospective trial. Ann Surg 2005; 241: 232-237 
[PMID: 15650632 DOI: 10.1097/01.sla.0000151892.35922.f2]
4 Shimizu S, Uchiyama A, Mizumoto K, Morisaki T, Nakamu-
ra K, Shimura H, Tanaka M. Laparoscopically assisted distal 
gastrectomy for early gastric cancer: is it superior to open 
surgery? Surg Endosc 2000; 14: 27-31 [PMID: 10653231 DOI: 
10.1007/s004649900005]
5 Gigot JF, Glineur D, Santiago Azagra J, Goergen M, Ceu-
terick M, Morino M, Etienne J, Marescaux J, Mutter D, van 
Krunckelsven L, Descottes B, Valleix D, Lachachi F, Bertrand 
C, Mansvelt B, Hubens G, Saey JP, Schockmel R. Laparo-
scopic liver resection for malignant liver tumors: preliminary 
results of a multicenter European study. Ann Surg 2002; 236: 
90-97 [PMID: 12131090 DOI: 10.1097/00000658-200207000-00
014]
6 Buunen M, Veldkamp R, Hop WC, Kuhry E, Jeekel J, Ha-
glind E, Påhlman L, Cuesta MA, Msika S, Morino M, Lacy A, 
Bonjer HJ. Survival after laparoscopic surgery versus open 
surgery for colon cancer: long-term outcome of a randomised 
clinical trial. Lancet Oncol 2009; 10: 44-52 [PMID: 19071061 
DOI: 10.1016/S1470-2045(08)70310-3]
7 McLeod R. Long-term results of laparoscopic-assisted col-
ectomy are comparable to results after open colectomy. 
Ann Surg 2008; 248: 8-9 [PMID: 18580200 DOI: 10.1097/
SLA.0b013e31817c965d]
8 Merchant NB, Parikh AA, Kooby DA. Should all distal pan-
createctomies be performed laparoscopically? Adv Surg 2009; 
43: 283-300 [PMID: 19845186 DOI: 10.1016/j.yasu.2009.02.013]
Kang CM et al . Minimally invasive radical distal pancreatectomy
2350 March 7, 2014|Volume 20|Issue 9|WJG|www.wjgnet.com
9 Kang CM, Choi SH, Hwang HK, Kim DH, Yoon CI, Lee WJ. 
Laparoscopic distal pancreatectomy with division of the 
pancreatic neck for benign and borderline malignant tumor 
in the proximal body of the pancreas. J Laparoendosc Adv 
Surg Tech A 2010; 20: 581-586 [PMID: 20629517 DOI: 10.1089/
lap.2009.0348]
10 Hayashi H, Ochiai T, Shimada H, Gunji Y. Prospective ran-
domized study of open versus laparoscopy-assisted distal 
gastrectomy with extraperigastric lymph node dissection for 
early gastric cancer. Surg Endosc 2005; 19: 1172-1176 [PMID: 
16132323 DOI: 10.1007/s00464-004-8207-4]
11 Strasberg SM, Drebin JA, Linehan D. Radical antegrade 
modular pancreatosplenectomy. Surgery 2003; 133: 521-527 
[PMID: 12773980 DOI: 10.1067/msy.2003.146]
12 Fernández-Cruz L, Cosa R, Blanco L, Levi S, López-Boado 
MA, Navarro S. Curative laparoscopic resection for pancre-
atic neoplasms: a critical analysis from a single institution. 
J Gastrointest Surg 2007; 11: 1607-1621; discussion 1621-1622 
[PMID: 17896167]
13 Kooby DA, Hawkins WG, Schmidt CM, Weber SM, Bentrem 
DJ, Gillespie TW, Sellers JB, Merchant NB, Scoggins CR, 
Martin RC, Kim HJ, Ahmad S, Cho CS, Parikh AA, Chu CK, 
Hamilton NA, Doyle CJ, Pinchot S, Hayman A, McClaine R, 
Nakeeb A, Staley CA, McMasters KM, Lillemoe KD. A multi-
center analysis of distal pancreatectomy for adenocarcinoma: 
is laparoscopic resection appropriate? J Am Coll Surg 2010; 
210: 779-785, 786-787 [PMID: 20421049]
14 Kang CM, Kim DH, Lee WJ. Ten years of experience with re-
section of left-sided pancreatic ductal adenocarcinoma: evo-
lution and initial experience to a laparoscopic approach. Surg 
Endosc 2010; 24: 1533-1541 [PMID: 20054579 DOI: 10.1007/
s00464-009-0806-7]
15 Strasberg SM, Linehan DC, Hawkins WG. Radical antegrade 
modular pancreatosplenectomy procedure for adenocarci-
noma of the body and tail of the pancreas: ability to obtain 
negative tangential margins. J Am Coll Surg 2007; 204: 244-249 
[PMID: 17254928 DOI: 10.1016/j.jamcollsurg.2006.11.002]
16 Fernández-Cruz L. Distal pancreatic resection: technical dif-
ferences between open and laparoscopic approaches. HPB 
(Oxford) 2006; 8: 49-56 [PMID: 18333239 DOI: 10.1080/136518
20500468059]
17 Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, 
Abrams RA, Sauter PK, Coleman J, Hruban RH, Lillemoe 
KD. Resected adenocarcinoma of the pancreas-616 patients: 
results, outcomes, and prognostic indicators. J Gastrointest 
Surg 2000; 4: 567-579 [PMID: 11307091 DOI: 10.1016/S1091-
255X(00)80105-5]
18 Goh BK, Tan YM, Cheow PC, Chung YF, Chow PK, Wong 
WK, Ooi LL. Outcome of distal pancreatectomy for pancreat-
ic adenocarcinoma. Dig Surg 2008; 25: 32-38 [PMID: 18292659 
DOI: 10.1159/000117821]
19 Christein JD, Kendrick ML, Iqbal CW, Nagorney DM, Farnell 
MB. Distal pancreatectomy for resectable adenocarcinoma of 
the body and tail of the pancreas. J Gastrointest Surg 2005; 9: 
922-927 [PMID: 16137585 DOI: 10.1016/j.gassur.2005.04.008]
20 Shoup M, Conlon KC, Klimstra D, Brennan MF. Is extended 
resection for adenocarcinoma of the body or tail of the pan-
creas justified? J Gastrointest Surg 2003; 7: 946-952; discussion 
952 [PMID: 14675703 DOI: 10.1016/j.gassur.2003.08.004]
21 Cho A, Yamamoto H, Kainuma O, Ota T, Park S, Ikeda A, 
Souda H, Nabeya Y, Takiguchi N, Nagata M. Pure laparo-
scopic distal pancreatectomy with en bloc celiac axis resec-
tion. J Laparoendosc Adv Surg Tech A 2011; 21: 957-959 [PMID: 
22054349 DOI: 10.1089/lap.2011.0300]
22 Mitchem JB, Hamilton N, Gao F, Hawkins WG, Linehan 
DC, Strasberg SM. Long-term results of resection of adeno-
carcinoma of the body and tail of the pancreas using radical 
antegrade modular pancreatosplenectomy procedure. J Am 
Coll Surg 2012; 214: 46-52 [PMID: 22192922 DOI: 10.1016/
j.jamcollsurg.2011.10.008]
23 Kooby DA, Gillespie T, Bentrem D, Nakeeb A, Schmidt MC, 
Merchant NB, Parikh AA, Martin RC, Scoggins CR, Ahmad 
S, Kim HJ, Park J, Johnston F, Strouch MJ, Menze A, Rymer 
J, McClaine R, Strasberg SM, Talamonti MS, Staley CA, Mc-
Masters KM, Lowy AM, Byrd-Sellers J, Wood WC, Hawkins 
WG. Left-sided pancreatectomy: a multicenter comparison 
of laparoscopic and open approaches. Ann Surg 2008; 248: 
438-446 [PMID: 18791364]
24 Laxa BU, Carbonell AM, Cobb WS, Rosen MJ, Hardacre JM, 
Mekeel KL, Harold KL. Laparoscopic and hand-assisted 
distal pancreatectomy. Am Surg 2008; 74: 481-486; discussion 
486-487 [PMID: 18556989]
25 Lebedyev A, Zmora O, Kuriansky J, Rosin D, Khaikin M, 
Shabtai M, Ayalon A. Laparoscopic distal pancreatectomy. 
Surg Endosc 2004; 18: 1427-1430 [PMID: 15791363 DOI: 
10.1007/s00464-003-8221-y]
26 Melotti G, Butturini G, Piccoli M, Casetti L, Bassi C, Mul-
lineris B, Lazzaretti MG, Pederzoli P. Laparoscopic distal 
pancreatectomy: results on a consecutive series of 58 patients. 
Ann Surg 2007; 246: 77-82 [PMID: 17592294 DOI: 10.1097/01.
sla.0000258607.17194.2b]
27 Taylor C, O’Rourke N, Nathanson L, Martin I, Hopkins G, 
Layani L, Ghusn M, Fielding G. Laparoscopic distal pancre-
atectomy: the Brisbane experience of forty-six cases. HPB 
(Oxford) 2008; 10: 38-42 [PMID: 18695757 DOI: 10.1080/13651
820701802312]
28 Gagner M, Pomp A, Herrera MF. Early experience with 
laparoscopic resections of islet cell tumors. Surgery 1996; 120: 
1051-1054 [PMID: 8957494 DOI: 10.1016/S0039-6060(96)80054-7]
29 Eom BW, Jang JY, Lee SE, Han HS, Yoon YS, Kim SW. Clini-
cal outcomes compared between laparoscopic and open dis-
tal pancreatectomy. Surg Endosc 2008; 22: 1334-1338 [PMID: 
18027035 DOI: 10.1007/s00464-007-9660-7]
30 Jayaraman S, Gonen M, Brennan MF, D’Angelica MI, DeMat-
teo RP, Fong Y, Jarnagin WR, Allen PJ. Laparoscopic distal 
pancreatectomy: evolution of a technique at a single institu-
tion. J Am Coll Surg 2010; 211: 503-509 [PMID: 20868976 DOI: 
10.1016/j.jamcollsurg.2010.06.010]
31 Borja-Cacho D, Al-Refaie WB, Vickers SM, Tuttle TM, Jensen 
EH. Laparoscopic distal pancreatectomy. J Am Coll Surg 2009; 
209: 758-765; quiz 800 [PMID: 19959046 DOI: 10.1016/j.jamcol
lsurg.2009.08.021]
32 D’Angelica M, Are C, Jarnagin W, DeGregoris G, Coit 
D, Jaques D, Brennan M, Fong Y. Initial experience with 
hand-assisted laparoscopic distal pancreatectomy. Surg 
Endosc 2006; 20: 142-148 [PMID: 16333550 DOI: 10.1007/
s00464-005-0209-3]
33 Dulucq JL, Wintringer P, Stabilini C, Feryn T, Perissat J, 
Mahajna A. Are major laparoscopic pancreatic resections 
worthwhile? A prospective study of 32 patients in a single 
institution. Surg Endosc 2005; 19: 1028-1034 [PMID: 16027987 
DOI: 10.1007/s00464-004-2182-7]
34 DiNorcia J, Schrope BA, Lee MK, Reavey PL, Rosen SJ, Lee 
JA, Chabot JA, Allendorf JD. Laparoscopic distal pancreatec-
tomy offers shorter hospital stays with fewer complications. 
J Gastrointest Surg 2010; 14: 1804-1812 [PMID: 20589446 DOI: 
10.1007/s11605-010-1264-1]
35 Kim J, Han HS, Yoon YS, Cho JY, Ahn KS, Kwon Y. Out-
comes of the patients who were postoperatively diagnosed 
as malignancy after laparoscopic distal pancreatectomy. 
Surg Laparosc Endosc Percutan Tech 2012; 22: 467-470 [PMID: 
23047395 DOI: 10.1097/SLE.0b013e3182632833]
36 Choi SH, Kang CM, Lee WJ, Chi HS. Multimedia article. 
Laparoscopic modified anterior RAMPS in well-selected left-
sided pancreatic cancer: technical feasibility and interim re-
sults. Surg Endosc 2011; 25: 2360-2361 [PMID: 21298529 DOI: 
10.1007/s00464-010-1556-2]
37 Song KB, Kim SC, Park JB, Kim YH, Jung YS, Kim MH, 
Lee SK, Seo DW, Lee SS, Park do H, Han DJ. Single-center 
experience of laparoscopic left pancreatic resection in 359 
Kang CM et al . Minimally invasive radical distal pancreatectomy
2351 March 7, 2014|Volume 20|Issue 9|WJG|www.wjgnet.com
consecutive patients: changing the surgical paradigm of left 
pancreatic resection. Surg Endosc 2011; 25: 3364-3372 [PMID: 
21556993 DOI: 10.1007/s00464-011-1727-9]
38 Choi SH, Kang CM, Hwang HK, Lee WJ, Chi HS. Robotic 
anterior RAMPS in well-selected left-sided pancreatic cancer. 
J Gastrointest Surg 2012; 16: 868-869 [PMID: 22258879 DOI: 
10.1007/s11605-012-1825-6]
39 Daouadi M, Zureikat AH, Zenati MS, Choudry H, Tsung A, 
Bartlett DL, Hughes SJ, Lee KK, Moser AJ, Zeh HJ. Robot-
assisted minimally invasive distal pancreatectomy is superior 
to the laparoscopic technique. Ann Surg 2013; 257: 128-132 
[PMID: 22868357 DOI: 10.1097/SLA.0b013e31825fff08]
40 Magge D, Gooding W, Choudry H, Steve J, Steel J, Zureikat 
A, Krasinskas A, Daouadi M, Lee KK, Hughes SJ, Zeh HJ, 
Moser AJ. Comparative effectiveness of minimally invasive 
and open distal pancreatectomy for ductal adenocarcinoma. 
JAMA Surg 2013; 148: 525-531 [PMID: 23426503 DOI: 10.1001/
jamasurg.2013.1673]
41 Marangos IP, Buanes T, Røsok BI, Kazaryan AM, Rosseland 
AR, Grzyb K, Villanger O, Mathisen Ø, Gladhaug IP, Edwin B. 
Laparoscopic resection of exocrine carcinoma in central and 
distal pancreas results in a high rate of radical resections and 
long postoperative survival. Surgery 2012; 151: 717-723 [PMID: 
22284762 DOI: 10.1016/j.surg.2011.12.016]
42 Shimada K, Sakamoto Y, Sano T, Kosuge T. Prognostic fac-
tors after distal pancreatectomy with extended lymphadenec-
tomy for invasive pancreatic adenocarcinoma of the body 
and tail. Surgery 2006; 139: 288-295 [PMID: 16546491 DOI: 
10.1016/j.surg.2005.08.004]
43 Farnell MB, Pearson RK, Sarr MG, DiMagno EP, Burgart LJ, 
Dahl TR, Foster N, Sargent DJ. A prospective randomized 
trial comparing standard pancreatoduodenectomy with pan-
creatoduodenectomy with extended lymphadenectomy in re-
sectable pancreatic head adenocarcinoma. Surgery 2005; 138: 
618-628; discussion 628-630 [PMID: 16269290 DOI: 10.1016/
j.surg.2005.06.044]
44 Pedrazzoli S, DiCarlo V, Dionigi R, Mosca F, Pederzoli P, 
Pasquali C, Klöppel G, Dhaene K, Michelassi F. Standard ver-
sus extended lymphadenectomy associated with pancreato-
duodenectomy in the surgical treatment of adenocarcinoma 
of the head of the pancreas: a multicenter, prospective, ran-
domized study. Lymphadenectomy Study Group. Ann Surg 
1998; 228: 508-517 [PMID: 9790340 DOI: 10.1097/00000658-19
9810000-00007]
45 Yeo CJ, Cameron JL, Lillemoe KD, Sohn TA, Campbell KA, 
Sauter PK, Coleman J, Abrams RA, Hruban RH. Pancreati-
coduodenectomy with or without distal gastrectomy and ex-
tended retroperitoneal lymphadenectomy for periampullary 
adenocarcinoma, part 2: randomized controlled trial evaluat-
ing survival, morbidity, and mortality. Ann Surg 2002; 236: 
355-366; discussion 366-368 [PMID: 12192322]
46 Yamamura K, Nakao A, Fujii T, Yamada S, Sugimoto H, Ka-
suya H, Nomoto S, Kodera Y, Nakamura S, Morita S, Takeda 
S. Clinicopathologic study of intrapancreatic cancer spread in 
carcinoma of the body and tail of the pancreas. Pancreas 2012; 
41: 753-758 [PMID: 22228052]
47 Nakao A, Fujii T, Sugimoto H, Kanazumi N, Nomoto S, 
Kodera Y, Inoue S, Takeda S. Oncological problems in 
pancreatic cancer surgery. World J Gastroenterol 2006; 12: 
4466-4472 [PMID: 16874856]
48 Kanda M, Fujii T, Sahin TT, Kanzaki A, Nagai S, Yamada 
S, Sugimoto H, Nomoto S, Takeda S, Kodera Y, Morita S, 
Nakao A. Invasion of the splenic artery is a crucial prognos-
tic factor in carcinoma of the body and tail of the pancreas. 
Ann Surg 2010; 251: 483-487 [PMID: 20101172 DOI: 10.1097/
SLA.0b013e3181cf9171]
49 Hirano S, Kondo S, Hara T, Ambo Y, Tanaka E, Shichinohe 
T, Suzuki O, Hazama K. Distal pancreatectomy with en bloc 
celiac axis resection for locally advanced pancreatic body 
cancer: long-term results. Ann Surg 2007; 246: 46-51 [PMID: 
17592290 DOI: 10.1097/01.sla.0000258608.52615.5a]
50 Okada K, Kawai M, Tani M, Hirono S, Miyazawa M, Shi-
mizu A, Kitahata Y, Yamaue H. Surgical strategy for patients 
with pancreatic body/tail carcinoma: who should undergo 
distal pancreatectomy with en-bloc celiac axis resection? 
Surgery 2013; 153: 365-372 [PMID: 23046987 DOI: 10.1016/
j.surg.2012.07.036]
51 Giulianotti PC, Addeo P, Buchs NC, Ayloo SM, Bianco 
FM. Robotic extended pancreatectomy with vascular 
resection for locally advanced pancreatic tumors. Pan-
creas 2011; 40: 1264-1270 [PMID: 21785385 DOI: 10.1097/
MPA.0b013e318220e3a4]
52 Boggi U, Signori S, De Lio N, Perrone VG, Vistoli F, Belluo-
mini M, Cappelli C, Amorese G, Mosca F. Feasibility of ro-
botic pancreaticoduodenectomy. Br J Surg 2013; 100: 917-925 
[PMID: 23640668 DOI: 10.1002/bjs.9135]
53 Kendrick ML, Sclabas GM. Major venous resection dur-
ing total laparoscopic pancreaticoduodenectomy. HPB 
(Oxford) 2011; 13: 454-458 [PMID: 21689228 DOI: 10.1111/
j.1477-2574.2011.00323.x]
54 Kang CM, Hwang HK, Choi SH, Lee WJ. Controversial is-
sues of neoadjuvant treatment in borderline resectable pan-
creatic cancer. Surg Oncol 2013; 22: 123-131 [PMID: 23518243 
DOI: 10.1016/j.suronc.2013.02.007]
55 Chang YR, Han SS, Park SJ, Lee SD, Yoo TS, Kim YK, Kim 
TH, Woo SM, Lee WJ, Hong EK. Surgical outcome of pancre-
atic cancer using radical antegrade modular pancreatosple-
nectomy procedure. World J Gastroenterol 2012; 18: 5595-5600 
[PMID: 23112553 DOI: 10.3748/wjg.v18.i39.5595]
56 Yamamoto J, Saiura A, Koga R, Seki M, Katori M, Kato Y, 
Sakamoto Y, Kokudo N, Yamaguchi T. Improved survival of 
left-sided pancreas cancer after surgery. Jpn J Clin Oncol 2010; 
40: 530-536 [PMID: 20363769 DOI: 10.1093/jjco/hyq015]
57 Takahashi S, Kinoshita T, Konishi M, Gotohda N, Kato Y, 
Kinoshita T, Kobayashi T, Mitsunaga S, Nakachi K, Ikeda M. 
Borderline resectable pancreatic cancer: rationale for multi-
disciplinary treatment. J Hepatobiliary Pancreat Sci 2011; 18: 
567-574 [PMID: 21331805 DOI: 10.1007/s00534-011-0371-z]
58 Stokes JB, Nolan NJ, Stelow EB, Walters DM, Weiss GR, 
de Lange EE, Rich TA, Adams RB, Bauer TW. Preoperative 
capecitabine and concurrent radiation for borderline resect-
able pancreatic cancer. Ann Surg Oncol 2011; 18: 619-627 
[PMID: 21213060 DOI: 10.1245/s10434-010-1456-7]
59 Kang CM, Chung YE, Park JY, Sung JS, Hwang HK, Choi 
HJ, Kim H, Song SY, Lee WJ. Potential contribution of preop-
erative neoadjuvant concurrent chemoradiation therapy on 
margin-negative resection in borderline resectable pancreatic 
cancer. J Gastrointest Surg 2012; 16: 509-517 [PMID: 22183861 
DOI: 10.1007/s11605-011-1784-3]
P- Reviewers: Camp ER, Nakao A, Stefaniak T 
S- Editor: Wen LL    L- Editor: A    E- Editor: Zhang DN
Kang CM et al . Minimally invasive radical distal pancreatectomy
© 2014 Baishideng Publishing Group Co., Limited. All rights reserved.
Published by Baishideng Publishing Group Co., Limited
Flat C, 23/F., Lucky Plaza, 
315-321 Lockhart Road, Wan Chai, Hong Kong, China
Fax: +852-65557188
Telephone: +852-31779906
E-mail: bpgoffice@wjgnet.com
http://www.wjgnet.com
I S S N  1 0  0 7  -   9  3 2  7
9    7 7 1 0  07   9 3 2 0 45
0  9
